Gut microbiota-derived imidazole propionate is associated with obesity
Frontiers in Nutrition · 03.08.2026 · 13
DOI: 10.3389/fnut.2026.1861257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 03.08.2026. Verfasst von Linwei Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity is a progressive metabolic disorder with some well-recognized markers, such as increased or elevated branched-chain amino acids (BCAAs). However, the role of gut microbiota-derived metabolites remains unknown in Asian populations. By employing an integrated multi-omics approach combining metagenomic and plasma metabolomic profiling in an Asian cohort alongside a longitudinal analysis of a bariatric surgery subgroup. We identified a distinct metabolic signature in obesity characterized by depleted circulating histidine and a concomitant elevation of Imidazole Propionate (ImP). The elevated ImP level not only positively correlated with the body mass index (BMI) but also increased progressively across obesity severity categories, and were associated with the taxonomic enrichment of ImP-producing species, such as Streptococcus mutans and Lactobacillus gasseri . Meanwhile, the ImP level showed rapid reduction within 3 months post-bariatric surgery. Collectively, our findings indicate that gut dysbiosis and histidine metabolism toward ImP production link with obesity and metabolic dysfunction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Zitieren
APA
Li, L., Wang, C., Liu, L., Xu, T., Nie, X., Liu, Y., Zhang, H., Yang, C., & Di, J. (2026). Gut microbiota-derived imidazole propionate is associated with obesity. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1861257
Vancouver
Li L, Wang C, Liu L, Xu T, Nie X, Liu Y, et al. Gut microbiota-derived imidazole propionate is associated with obesity. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1861257
BibTeX
@article{Li2026,
author = {Li, Linwei and Wang, Chen and Liu, Luyao and Xu, Ting and Nie, Xiaoqun and Liu, Yujie and Zhang, Hongwei and Yang, Chen and Di, Jianzhong},
title = {Gut microbiota-derived imidazole propionate is associated with obesity},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1861257}
}
EUVIMED